February 23, 2012 – According to a new survey issued by the Heart Rhythm Society (HRS), the majority of Americans are unaware of two serious and potentially life-threatening heart rhythm disorders, atrial fibrillation (AF) and sudden cardiac arrest (SCA).
February 23, 2012 — AstraZeneca announced that the American College of Chest Physicians (ACCP) has updated its guidelines on Antithrombotic Therapy and Prevention of Thrombosis to include a recommendation for giving the oral antiplatelet medicine, BRILINTA (ticagrelor) tablets with low-dose aspirin, to patients who suffer from acute coronary syndrome (ACS).
Teleflex Inc. announced a new agreement with HealthTrust Purchasing Group L.P. (HealthTrust), for its Arrow Intra-Aortic Balloon Pump and Catheter products. The new agreement begins March 1, 2012 and extends through Feb. 28, 2015.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 23, 2012 — At the European Congress of Radiology taking place March 1-5, Spellman High Voltage Electronics Corp. and K&S Röntgenwerk will exhibit together for the first time at the Austria Center Vienna under the name Spellman High Voltage GmbH.
February 22, 2012 — Attendees at the HIMSS 2012 meeting in Las Vegas were given a preview of what will be in the expected proposed rules for Stage 2 meaningful use, certification and standards from officials at the Office of the National Coordinator for Health IT (ONC) and the Centers for Medicare and Medicaid Services (CMS). In a recap featured on its website, HIMSS reported that Farzad Mostashari, National Coordinator for Health Information Technology, told attendees, “We stayed the course.” He also noted that image viewing will be an option for meaningful use (MU).
U.S. Department of Health and Human Services’ (HHS) Secretary Kathleen Sebelius announced the number of hospitals using health information technology (IT) has more than doubled in the last two years. She also announced new data showing that nearly 2,000 hospitals and more than 41,000 doctors have received $3.1 billion in incentive payments for ensuring meaningful use of health IT, particularly certified electronic health records (EHR).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 22, 2012 — HeartWare International Inc. announced that a U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel will review the premarket approval (PMA) application for the HeartWare Ventricular Assist Device system on April 25, 2012.
February 22, 2012 — Cardiologists are expecting to use fewer imaging modalities per patient case in the future, according to a new report released by market research firm IMV Medical Information Division.
February 21, 2012 — Circadence, a provider of WAN and network optimization solutions for healthcare, announced a set of solutions for optimizing electronic content delivery to iOS, Android and Windows clients.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
A comparison of HIMSS Analytics data from September 2011 to December 2011 suggests that a number of hospital segments showed increased capability to achieve Stage 1 of meaningful use.
February 20, 2012 — ReCor Medical announced that its Paradise percutaneous ultrasound renal denervation system for achieving rhas received the CE mark. Paradise is designed to treat patients with resistant hypertension (HTN), a major risk factor for cardiovascular disease.
February 20, 2012 —Medtronic announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity drug-eluting stent (DES) for the treatment of coronary artery disease (CAD).
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 20, 2012 — U.S. Senate and House legislators have reached a “doc fix” agreement this week to prevent slashing payments to physicians treating Medicare patients. A law was to take effect at the beginning of March would have reduced reimbursements by 27 percent.
February 20, 2012 — Edwards Lifesciences Corp. announced that it received CE mark in Europe for its Edwards Intuity valve system for use in patients undergoing surgical aortic valve replacement (AVR).
February 20, 2012 — BG Medicine, Inc. announced positive results from its pivotal validation study for the CardioSCORE diagnostic test, previously known by the development name AMIPredict.